Andrew McKibbin
SVP of Strategic Finance and Investor Relations
Replay available
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) Q3 2025 earnings conference call, held 2025-11-04. Replay captured from the company's public earnings webcast.

SVP of Strategic Finance and Investor Relations
Chief Executive Officer
President and Chief Operating Officer
Chief Medical Officer
Chief Financial Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Mirum Pharmaceuticals, Inc..
WEBVTT 00:00:00.065 -- 00:00:04.711 Hello and welcome to the Mirim Pharmaceutical third quarter 2025 financial results and 00:00:04.711 -- 00:00:08.716 business update. My name is Harry and I'll be your operator today. 00:00:08.716 -- 00:00:12.522 All lines are currently in listen-only mode and there'll be an opportunity for Q&A after 00:00:12.522 -- 00:00:16.707 management's prepared remarks. To enter the queue for questions, please press star followed 00:00:16.707 -- 00:00:21.073 by one on your telephone keypad. I would now like to hand the conference over to Andrew 00:00:21.073 -- 00:00:24.437 McKibbin, SVP of Strategic Finance and Investor Relations. 00:00:24.437 -- 00:00:26.738 Please go ahead. 00:00:27.200 -- 00:00:29.403 Thanks, Harry, and good afternoon, everyone. 00:00:29.403 -- 00:00:33.910 I'd like to welcome you to Miriam Pharmaceuticals' third quarter 2025 conference call. 00:00:33.910 -- 00:00:38.076 I'm joined today by our CEO, Chris Peets, our President and Chief Operating Officer, 00:00:38.076 -- 00:00:42.722 Peter Radovich, our Chief Medical Officer, Joanne Kwan, and Eric Bierkle, our Chief Financial 00:00:42.722 -- 00:00:46.748 Officer. Earlier today, Miriam issued a news release announcing the company's results 00:00:46.748 -- 00:00:48.891 for the third quarter 2025. 00:00:48.891 -- 00:00:52.556 Copies of this news release and SEC filings can be found in the Investors section of 00:00:52.556 -- 00:00:56.460 our website. Before we start, I'd like to remind you that during the course of this conference 00:00:56.460 -- 00:01:00.165 call, we will be making certain forward-looking statements based on management's current 00:01:00.165 -- 00:01:04.150 expectations, including statements regarding Miriam's programs and market opportunities 00:01:04.150 -- ...